Cranial involvement in giant cell arteritis.
Bosch, Philipp Espigol-Frigolé, Georgina Cid, Maria C Mollan, Susan P Schmidt, Wolfgang A
Bosch, Philipp
Espigol-Frigolé, Georgina
Cid, Maria C
Mollan, Susan P
Schmidt, Wolfgang A
Citations
Altmetric:
Affiliation
Other Contributors
Publication date
2024-04-01
Subject
Collections
Research Projects
Organizational Units
Journal Issue
Abstract
Since its first clinical description in 1890, extensive research has advanced our understanding of giant cell arteritis, leading to improvements in both diagnosis and management for affected patients. Imaging studies have shown that the disease frequently extends beyond the typical cranial arteries, also affecting large vessels such as the aorta and its proximal branches. Meanwhile, advances in comprehending the underlying pathophysiology of giant cell arteritis have given rise to numerous potential therapeutic agents, which aim to minimise the need for glucocorticoid treatment and prevent flares. Classification criteria for giant cell arteritis, as well as recommendations for management, imaging, and treat-to-target have been developed or updated in the last 5 years, and current research encompasses a broad spectrum covering basic, translational, and clinical research. In this Series paper, we aim to discuss the current understanding of giant cell arteritis with cranial manifestations, describe the clinical approach to this condition, and explore future directions in research and patient care.
Citation
Bosch P, Espigol-Frigolé G, Cid MC, Mollan SP, Schmidt WA. Cranial involvement in giant cell arteritis. Lancet Rheumatol. 2024 Jun;6(6):e384-e396. doi: 10.1016/S2665-9913(24)00024-9. Epub 2024 Apr 1.
Type
Article
Other
Other